Shane Gong, who previously led the Singapore office at Australia's CHAMP Private Equity, now CPE Capital, has been recruited by Evercore to head up its PE secondaries business in Asia.
Gong will serve as a Singapore-based managing director in the firm's private capital advisory group with responsibility for institutional investor and fund sponsor relationships across Asia Pacific. The...
Suzhou Medilink Therapeutics, a Chinese biotech company specializing in antibody-drug conjugates (ADCs) commonly used as targeted therapies for treating cancer, has raised $50 million in Series A funding across two tranches.
OrbiMed has closed its latest Asia life sciences fund, which primarily invests in China and India, with $800 million in commitments.
Tuya, a Chinese software platform for internet-of-things (IoT) systems that mainly offers platform-as-a-service (PaaS) products is pursuing a US IPO.